Effects of Semantic Context on Criterion-learning Naming Treatment in Aphasia

ConditionAphasia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorAlbert Einstein Healthcare Network

About this trial

Aphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today. A common problem in aphasia involves difficulty retrieving known words in the course of language production and comprehension. The overarching goal of this project is to develop and test early efficacy, efficiency, and the tolerability of a lexical treatment for aphasia in multiple-session regimens that are comprised of retrieval practice, distributed practice, and training dedicated to the elicitation of correct retrievals. The aim of this work is to add to and refine the evidence base for the implementation and optimization of these elements in the treatment of production and comprehension deficits in aphasia, and make important steps towards an ultimate goal of self-administered lexical treatment grounded in retrieval practice principles (RPP) to supplement traditional speech-language therapy that is appropriate for People with Aphasia (PWA) from a broad level of severity of lexical processing deficit in naming and/or comprehension. This project cumulatively builds on prior work to develop a theory of learning for lexical processing impairment in aphasia that aims to ultimately explain why and for whom familiar lexical treatments work, and how to maximize the benefits they confer.

Eligibility criteria

Qualifiers

English as a native or primary language

Adults with stroke who are at least 6 months post-onset

Disqualifiers

History of comorbid neurological diagnoses, such as Multiple Sclerosis or Parkinson's Disease

History of a learning disability that significantly impacted language development, such as developmental language disorder

Insufficient stamina to participate in the protocol

Trial design

Treatments tested in this trial

  • Criterion-learning practice

Treatment groups

12 Participants
are divided into 1 treatment group

Sponsors and collaborators

Albert Einstein Healthcare Network

Lead sponsor

Thomas Jefferson University

Collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator